$1.02 Billion is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 68 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 193.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | New | ISHARES TRput | $134,508,000 | – | 865,000 | +100.0% | 13.22% | – |
QQQ | New | INVESCO QQQ TRput | $48,552,000 | – | 260,000 | +100.0% | 4.77% | – |
BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $43,852,000 | +0.9% | 1,001,410 | +18.6% | 4.31% | -25.8% |
MSFT | Buy | MICROSOFT CORP | $38,656,000 | +21.4% | 288,567 | +6.9% | 3.80% | -10.8% |
FCX | New | FREEPORT-MCMORAN INCcl b | $36,466,000 | – | 3,140,882 | +100.0% | 3.58% | – |
XBI | New | SPDR SERIES TRUSTput | $35,084,000 | – | 400,000 | +100.0% | 3.45% | – |
ERI | Buy | ELDORADO RESORTS INC | $33,650,000 | +20.5% | 730,401 | +22.1% | 3.31% | -11.4% |
AMZN | Buy | AMAZON COM INC | $25,833,000 | +7.7% | 13,642 | +1.3% | 2.54% | -20.9% |
BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $25,418,000 | – | 150,000 | +100.0% | 2.50% | – |
ZBRA | New | ZEBRA TECHNOLOGIES CORPcl a | $25,358,000 | – | 121,047 | +100.0% | 2.49% | – |
ARMK | New | ARAMARK | $23,493,000 | – | 651,500 | +100.0% | 2.31% | – |
COTY | New | COTY INC | $22,151,000 | – | 1,653,061 | +100.0% | 2.18% | – |
CSTM | Buy | CONSTELLIUM NVcl a | $20,775,000 | +25.9% | 2,069,219 | +0.1% | 2.04% | -7.4% |
BA | New | BOEING CO | $18,524,000 | – | 50,890 | +100.0% | 1.82% | – |
HUYA | New | HUYA INC | $16,192,000 | – | 655,282 | +100.0% | 1.59% | – |
PFE | New | PFIZER INCput | $13,663,000 | – | 315,400 | +100.0% | 1.34% | – |
UNH | New | UNITEDHEALTH GROUP INC | $13,497,000 | – | 55,312 | +100.0% | 1.33% | – |
DIS | New | DISNEY WALT CO | $13,381,000 | – | 95,823 | +100.0% | 1.32% | – |
REGN | New | REGENERON PHARMACEUTICALS | $12,793,000 | – | 40,871 | +100.0% | 1.26% | – |
NOMD | Buy | NOMAD FOODS LTD | $12,713,000 | +12.6% | 595,199 | +7.8% | 1.25% | -17.2% |
FLXN | Buy | FLEXION THERAPEUTICS INC | $11,426,000 | +3.6% | 928,924 | +5.1% | 1.12% | -23.9% |
ATNX | Buy | ATHENEX INC | $11,245,000 | +70.5% | 567,935 | +5.5% | 1.10% | +25.3% |
ZBH | Buy | ZIMMER BIOMET HLDGS INC | $11,036,000 | +31.4% | 93,731 | +42.5% | 1.08% | -3.4% |
ARQL | New | ARQULE INC | $10,855,000 | – | 985,917 | +100.0% | 1.07% | – |
SAFM | New | SANDERSON FARMS INC | $10,548,000 | – | 77,238 | +100.0% | 1.04% | – |
EDU | New | NEW ORIENTAL ED & TECH GRP Ispon adr | $9,842,000 | – | 101,903 | +100.0% | 0.97% | – |
CNC | New | CENTENE CORP DEL | $9,784,000 | – | 186,583 | +100.0% | 0.96% | – |
SESN | Buy | SESEN BIO INC | $9,249,000 | +71.4% | 6,166,175 | +17.7% | 0.91% | +25.9% |
RPD | Buy | RAPID7 INC | $8,724,000 | +72.4% | 150,825 | +50.8% | 0.86% | +26.7% |
DIS | New | DISNEY WALT COcall | $8,378,000 | – | 60,000 | +100.0% | 0.82% | – |
AGN | New | ALLERGAN PLC | $8,372,000 | – | 50,000 | +100.0% | 0.82% | – |
GTYH | New | GTY TECHNOLOGY HOLDINGS INC | $8,220,000 | – | 1,200,000 | +100.0% | 0.81% | – |
AAL | New | AMERICAN AIRLS GROUP INC | $7,775,000 | – | 238,428 | +100.0% | 0.76% | – |
DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $6,683,000 | +55.6% | 296,346 | +60.2% | 0.66% | +14.5% |
ATHM | New | AUTOHOME INCput | $6,370,000 | – | 74,400 | +100.0% | 0.63% | – |
OSW | Buy | ONESPAWORLD HOLDINGS LIMITED | $6,212,000 | +338.4% | 400,750 | +286.2% | 0.61% | +223.3% |
PTCT | New | PTC THERAPEUTICS INC | $6,175,000 | – | 137,219 | +100.0% | 0.61% | – |
ADPT | New | ADAPTIVE BIOTECHNOLOGIES COR | $5,555,000 | – | 115,000 | +100.0% | 0.55% | – |
ARRY | New | ARRAY BIOPHARMA INC | $4,465,000 | – | 96,380 | +100.0% | 0.44% | – |
CARA | New | CARA THERAPEUTICS INC | $4,311,000 | – | 200,500 | +100.0% | 0.42% | – |
MTEM | Buy | MOLECULAR TEMPLATES INC | $4,307,000 | +44.1% | 515,792 | +0.3% | 0.42% | +6.0% |
SLGL | Buy | SOL GEL TECHNOLOGIES | $2,828,000 | +74.1% | 310,594 | +29.4% | 0.28% | +28.1% |
GNCA | New | GENOCEA BIOSCIENCES INC | $2,612,000 | – | 666,222 | +100.0% | 0.26% | – |
DCPH | New | DECIPHERA PHARMACEUTICALS INput | $2,255,000 | – | 100,000 | +100.0% | 0.22% | – |
AITB | New | AIT THERAPEUTICS INC | $2,225,000 | – | 400,859 | +100.0% | 0.22% | – |
DELL | Buy | DELL TECHNOLOGIES INCcl c | $378,000 | -8.7% | 7,446 | +5.6% | 0.04% | -32.7% |
MRNA | New | MODERNA INCput | $157,000 | – | 10,700 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
ISHARES TR | 27 | Q3 2023 | 13.2% |
HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
AMAZON COM INC | 18 | Q3 2022 | 7.6% |
SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-04-15 |
13F-HR/A | 2024-03-18 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2023-11-29 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.